Procedures & recovery · patient guide

TAVR and TAVI in China: Interpreting the Hospital's Preliminary Reply

A hospital reply is not one thing. It may only confirm that your records arrived, it may ask for missing documents before any clinical review, or it may say a heart team has begun formal assessment. The wording matters because only the last of these starts the clinical process. Ask which stage your case has reached.

Go to the practical guidance ↓
Editorial illustration: TAVR and TAVI in China: Interpreting the Hospital's Preliminary Reply
Illustrative image; not a photograph of a named hospital or an identified patient.
In this guide

Three different replies that all sound like progress

When an overseas patient sends records to a Chinese hospital about TAVR or TAVI, the first reply often arrives quickly and reads positively. That does not mean the same thing in every case. In practice, replies fall into three broad types, and each one leaves you in a different position.

A receipt reply confirms only that your file arrived and was logged. It says nothing about whether a clinician has looked at the valve images, whether the case fits the hospital's TAVR pathway, or whether a bed could be arranged. A records-request reply means someone has noticed gaps: perhaps the echocardiogram report is missing, or the CT images were sent as low-resolution screenshots rather than the original files. This is useful, because it tells you what the reviewing team wants before it will proceed. A formal-assessment reply is different again. It usually names a heart team, a review meeting, or a specific question the clinicians want answered, such as whether the valve anatomy is suitable for a catheter-based approach.

The practical point is simple. Before you respond, decide which category your reply belongs to. If you cannot tell, ask directly: has a clinician reviewed my records yet, or is this still an administrative acknowledgement? That single question changes what you do next.

What a heart team actually needs to judge valve suitability

TAVI, also called TAVR, replaces the aortic valve using a catheter-based procedure. That description tells you the treatment exists; it does not tell you whether it fits a particular patient. The decision belongs to a heart team, and the heart team works from images and measurements, not from a summary paragraph.

This is why the quality of what you send matters more than the quantity. A cardiologist reviewing a possible TAVR case will typically want to see the original echocardiogram study, the CT images used for valve and access-vessel assessment, and the reports that describe valve gradients, chamber dimensions, and coronary anatomy. If your reply asks for 'the CT disc' or 'the full echo study', that is a signal that the team is preparing for a genuine review rather than filing paperwork.

You do not need to guess which specific measurements the team will use. You do need to make sure the source files are available. Ask the hospital's international office whether they want DICOM files uploaded to a portal, sent by courier, or brought in person. Ask whether a radiology report alone is enough or whether the images themselves are required. These are administrative questions with clinical consequences, and the receiving team is the only reliable source for the answers.

The device question: ask it plainly

Patients often assume that 'TAVR is available' means a specific valve model is available for them. Those are different statements. Hospitals may offer a TAVR programme while using different devices, and device selection depends on anatomy, access route, sizing, and the team's own protocols. None of that can be settled from a general reply.

If your preliminary reply mentions a device by name, ask what that means for your case. Is this the device the team proposes, or one option among several? Does the choice depend on a measurement that has not yet been made? If the reply does not mention a device at all, that is normal at the receipt stage, but it is a fair question once formal assessment begins.

Avoid treating a device name in a reply as a confirmed plan. It may reflect the hospital's general stock or a preliminary impression. The heart team decides the final choice after reviewing your imaging, and that decision can change if the anatomy or access vessels turn out to be different from what the referral summary suggested.

Admission, timing and the reviews that come later

A reply that says assessment has started is not a reply that says a date is set. Admission timing depends on the hospital's own scheduling, the completeness of your workup, and whether any additional tests are needed in China before the team will proceed. No responsible hospital can promise a fixed interval from first contact to procedure, and you should be cautious of any reply that does.

Ask the international office how the process is structured. Will there be a pre-procedure clinic visit? Will the heart team meet again after any in-China tests? Who will explain the plan and the consent discussion, and in what language? These questions matter because TAVR decisions are often revisited once the team has its own imaging and has examined the patient.

It also helps to ask what happens after the procedure. Follow-up imaging, medication review, and the timing of any return to your home country are clinical decisions, not travel logistics. The treating team should tell you what it expects, and your local cardiologist should be involved in planning the handover. A hospital reply will not normally cover this, so raise it explicitly.

A short sequence for handling the reply you have

Work through the reply in order rather than replying immediately with everything you have. First, classify it: receipt, records request, or formal assessment. Second, if records are requested, send exactly what was asked for and confirm receipt in writing. Third, if assessment has started, ask which clinician or team is reviewing the case and what the next decision point is. Fourth, if the reply is ambiguous, ask the one clarifying question about whether clinical review has begun.

Keep a simple written record of what you sent and when. If you are working through an intermediary, ask them to confirm what was actually forwarded, because partial forwarding is a common reason for a records request that looks unnecessary from your side.

If a step cannot be completed, say so rather than leaving it silent. For example, if the original CT images are held by a hospital that will not release them quickly, tell the reviewing team and ask whether a repeat scan in China would be acceptable or whether they would rather wait. That is a question for the clinicians, and their answer may change the sequence.

What a reply does not confirm, and where to go next

No preliminary reply confirms that you are a candidate for TAVR, that a device is reserved for you, that a bed is available, or that travel is advisable. Those are clinical and administrative decisions that follow a proper review. A reply that sounds encouraging may still be an early-stage acknowledgement.

If you want help gathering records, arranging interpretation, or requesting a specialist appointment, ChinaSpecialistCare can assist with those coordination steps. An initial enquiry is free and does not require buying a proxy consultation. The hospital and its heart team decide suitability, and any clinical questions about your valve anatomy, the proposed device, or the timing of admission and later reviews should be put to them directly.

The most useful next step is usually a short, specific message back to the hospital: confirm which stage your case has reached, ask what is still missing, and ask when the heart team expects to review the file. That keeps the process moving without assuming an outcome that has not been given.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. British Heart Foundation: TAVI

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.